THERANOSTICS 2016* Daniel Kaemmerer
Zentralklinik Bad Berka, , Germany
Presentations this author is a contributor to:
Efficacy of peptide receptor radionuclide therapy in neuroendocrine neoplasms: the Bad Berka experience in 1048 patients over more than a decade (#64)
8:30 AM
Harshad R Kulkarni
Conference Breakfast: Moderated Poster Walk - Neuroendocrine tumours
Evaluation of Somatostatin, CXCR4 Chemokine and Endothelin A Receptor Expression in a Large Series of Paragangliomas (#16)
4:15 PM
Aviral Singh
Optimising Peptide Receptor Radionuclide Therapy (PRRT) - (submitted abstracts)